Chen D, Liu P, Lin J, Zang L, Liu Y, Zhai S
Adv Sci (Weinh). 2024; 12(7):e2406624.
PMID: 39739618
PMC: 11831569.
DOI: 10.1002/advs.202406624.
Liu Z, Han L, Ji X, Wang X, Jian J, Zhai Y
Front Immunol. 2024; 15:1486652.
PMID: 39726597
PMC: 11670203.
DOI: 10.3389/fimmu.2024.1486652.
Hu L, Zhang Q
Cell Insight. 2024; 3(5):100197.
PMID: 39279883
PMC: 11402294.
DOI: 10.1016/j.cellin.2024.100197.
Lelliott E, Naddaf J, Ganio K, Michie J, Wang S, Liu L
Cell Death Differ. 2024; 31(12):1707-1716.
PMID: 39261596
PMC: 11618339.
DOI: 10.1038/s41418-024-01369-4.
Sun C, Zhan J, Li Y, Zhou C, Huang S, Zhu X
J Cell Mol Med. 2024; 28(8):e18348.
PMID: 38652105
PMC: 11037416.
DOI: 10.1111/jcmm.18348.
Emerging roles of TBK1 in cancer immunobiology.
Miranda A, Shirley C, Jenkins R
Trends Cancer. 2024; 10(6):531-540.
PMID: 38519366
PMC: 11168882.
DOI: 10.1016/j.trecan.2024.02.007.
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death.
Clucas J, Meier P
Nat Rev Mol Cell Biol. 2023; 24(11):835-852.
PMID: 37568036
DOI: 10.1038/s41580-023-00623-w.
Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer.
Lim J, Lee E, Lee S, Cho H, Ahn D, Hwang Y
Transl Lung Cancer Res. 2023; 12(4):857-876.
PMID: 37197639
PMC: 10183402.
DOI: 10.21037/tlcr-22-633.
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.
Ito Y, Pan D, Zhang W, Zhang X, Juan T, Pyrdol J
Cancer Discov. 2023; 13(5):1186-1209.
PMID: 36811466
PMC: 10164097.
DOI: 10.1158/2159-8290.CD-22-1125.
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
Sahu A, Wang X, Munson P, Klomp J, Wang X, Gu S
Cancer Discov. 2023; 13(3):672-701.
PMID: 36745048
PMC: 9975674.
DOI: 10.1158/2159-8290.CD-22-0244.
The Function and Therapeutic Implications of TNF Signaling in MDSCs.
Yu K, Yu C, Jiao L, Miao K, Ni L, Rao X
Biomolecules. 2022; 12(11).
PMID: 36358977
PMC: 9687347.
DOI: 10.3390/biom12111627.
PP6 negatively modulates LUBAC-mediated M1-ubiquitination of RIPK1 and c-FLIP to promote TNFα-mediated cell death.
Wu G, Li D, Liang W, Sun W, Xie X, Tong Y
Cell Death Dis. 2022; 13(9):773.
PMID: 36071040
PMC: 9452587.
DOI: 10.1038/s41419-022-05206-9.
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W, Wang X, Zhou Y, Wang X, Yu Y
Signal Transduct Target Ther. 2022; 7(1):196.
PMID: 35725836
PMC: 9208265.
DOI: 10.1038/s41392-022-01046-3.
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activation.
Sorrentino A, Menevse A, Michels T, Volpin V, Durst F, Sax J
J Immunother Cancer. 2022; 10(5).
PMID: 35606086
PMC: 9174898.
DOI: 10.1136/jitc-2021-004258.
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.
Cristiani C, Capone M, Garofalo C, Madonna G, Mallardo D, Tuffanelli M
Front Immunol. 2022; 13:811131.
PMID: 35173725
PMC: 8841353.
DOI: 10.3389/fimmu.2022.811131.
Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
Zheng Z, Mao S, Zhang W, Liu J, Li C, Wang R
Front Oncol. 2021; 10:542492.
PMID: 33392066
PMC: 7773013.
DOI: 10.3389/fonc.2020.542492.
Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment.
Gong K, Guo G, Beckley N, Zhang Y, Yang X, Sharma M
Neoplasia. 2020; 23(2):189-196.
PMID: 33373873
PMC: 7773536.
DOI: 10.1016/j.neo.2020.12.006.
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities.
Shen M, Kang Y
Genes Dev. 2020; 34(23-24):1577-1598.
PMID: 33262145
PMC: 7706714.
DOI: 10.1101/gad.343251.120.
